Pharmaceutical company Galderma has released data that suggest the sequence of injectable treatments may influence skin-quality outcomes in menopausal women. An eight-month investigator-initiated trial, led by plastic surgeon Mr Andreas
Skincare company ALASTIN from pharmaceutical company Galderma has reintroduced its Restorative Skin Complex with an updated formula. The company shares that the new formulation includes TriHex+ Technology, which is enhanced
Pharmaceutical company Galderma has released topline results from a randomised study evaluating its hyaluronic acid filler, Restylane Volyme, for moderate-to-severe temple hollowing. The study, involving 162 patients in China, found
Pharmaceutical company Galderma has been confirmed as a Silver Sponsor for The Aesthetics Awards 2027. Galderma will celebrate the leading clinics in the South of England through the Galderma Award
A dual approach with Sculptra® and Restylane® SkinboostersTM can help patients achieve smoother, brighter and more resilient-looking summer skin by addressing both derma structure and skin quality Summer is often associated with healthy, luminous skin, yet the season can also …
Pharmaceutical company Galderma has secured European Union approval under the Medical Device Regulation for Restylane Shaype for chin augmentation. Powered by NASHA HD technology, the injectable is indicated for deep
The Clinical Cosmetic Regenerative Congress (CCR) will bring together a two-day educational programme spanning multiple stages and formats. Sessions will take place across The Innovation Forum, the Dentists in Aesthetic
Galderma explores the role of Restylane SkinboostersTM in structured treatment cycles for deep hydration and sustained skin quality improvement For many patients, ‘good skin’ is no longer just about smoothing a line or filling a fold. Increasingly, they are asking …
Pharmaceutical company Galderma welcomed press and specialty guests to a healthcare practitioner-led Open Clinic at The Londoner Hotel on June 30. Guests were invited to undergo a personalised skin analysis
Harnessing Sculptra body to address skin quality concerns beyond the face Sculptra is made with the unique PLLA-SCA™, its proprietary form of poly-L-lactic acid (PLLA).1,2,3 Slow degradation of Sculptra’s PLLA-SCA™ provides continuous regenerative biostimulation, characterised by early onset of tissue …
